Business · 14/03/2024Updated: 10/17/2026 · 1 min read
FDA Corrects Withdrawal of Approval for Two New Drug Applications
Summary
The FDA is correcting a notice that withdrew approval of two new drug applications, NDA 022424, due to a request from the applicant, Chartwell RX Sciences, LLC, which was not timely submitted.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →
Related companies